{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:12:03Z","timestamp":1790849523183,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,7,10]],"date-time":"2011-07-10T00:00:00Z","timestamp":1310256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s10456-011-9223-3","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T14:43:03Z","timestamp":1310222583000},"page":"393-405","source":"Crossref","is-referenced-by-count":29,"title":["Cellular level characterization of capillary regression in inflammatory angiogenesis using an in vivo corneal model"],"prefix":"10.1007","volume":"14","author":[{"given":"Beatrice Bourghardt","family":"Peebo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Fagerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Traneus-R\u00f6ckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Lagali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,10]]},"reference":[{"key":"9223_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0092-8674(93)80047-I","volume":"74","author":"RA Lang","year":"1993","unstructured":"Lang RA, Bishop JM (1993) Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 74:453\u2013462","journal-title":"Cell"},{"key":"9223_CR2","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1242\/dev.122.12.3929","volume":"122","author":"A Meeson","year":"1996","unstructured":"Meeson A, Palmer M, Calfon M, Lang R (1996) A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis. Development 122:3929\u20133938","journal-title":"Development"},{"key":"9223_CR3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0733-8635(18)30218-3","volume":"11","author":"RA Clark","year":"1993","unstructured":"Clark RA (1993) Biology of dermal wound repair. Dermatol Clin 11:647\u2013666","journal-title":"Dermatol Clin"},{"key":"9223_CR4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.jidsymp.5650008","volume":"11","author":"GE Davis","year":"2006","unstructured":"Davis GE, Saunders WB (2006) Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. J Invest Dermatol 11:44\u201356. doi: 10.1038\/sj.jidsymp.5650008","journal-title":"J Invest Dermatol"},{"key":"9223_CR5","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1167\/iovs.07-0113","volume":"48","author":"J Shen","year":"2007","unstructured":"Shen J, Xie B, Dong A, Swaim M, Hackett SF, Campochiaro PA (2007) In vivo immunostaining demonstrates macrophages associated with growing and regressing vessels. Invest Ophthalmol Vis Sci 48:4335\u20134341. doi: 10.1167\/iovs.07-0113","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9223_CR6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature03928","volume":"15","author":"IB Lobov","year":"2005","unstructured":"Lobov IB, Sujata R, Carrol TJ et al (2005) WNT7b mediates macrophage-induced programmed cell death in pattering of the vasculature. Nature 15:417\u2013421. doi: 10.1038\/nature03928","journal-title":"Nature"},{"key":"9223_CR7","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1167\/iovs.07-1491","volume":"49","author":"MH Davies","year":"2008","unstructured":"Davies MH, Stempel AJ, Powers MR (2008) MCP-1deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy. Invest Ophthalmol Vis Sci 49:4195\u20134202. doi: 10.1167\/iovs.07-1491","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9223_CR8","first-page":"771","volume":"74","author":"U Modlich","year":"1996","unstructured":"Modlich U, Kaup FJ, Augustin HG (1996) Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest 74:771\u2013780","journal-title":"Lab Invest"},{"key":"9223_CR9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s11605-008-0507-x","volume":"12","author":"B Hotz","year":"2008","unstructured":"Hotz B, Buhr HJ, Hotz HG (2008) Intravital microscopic characterization of suramin effects in an orthotopic immunocompetent rat model of pancreatic cancer. J Gastrointest Surg 12:900\u2013906. doi: 10.1007\/s11605-008-0507-x","journal-title":"J Gastrointest Surg"},{"key":"9223_CR10","first-page":"284","volume":"3","author":"DH Ausprunk","year":"1978","unstructured":"Ausprunk DH, Falterman K, Folkman J (1978) The sequence of events in the regression of corneal capillaries. Lab Invest 3:284\u2013294","journal-title":"Lab Invest"},{"key":"9223_CR11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.ico.0000183485.85636.ff","volume":"25","author":"C Cursiefen","year":"2006","unstructured":"Cursiefen C, Maruyama K, Jackson DG, Streilen W, Kruse FE (2006) Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 25:443\u2013447. doi: 10.1097\/01.ico.0000183485.85636.ff","journal-title":"Cornea"},{"key":"9223_CR12","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1167\/iovs.05-1656","volume":"47","author":"BR Mwaikambo","year":"2006","unstructured":"Mwaikambo BR, Sennlaub F, Ong H, Chemtob S, Hardy P (2006) Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization. Invest Ophthalmol Vis Sci 47:4356\u20134364. doi: 10.1167\/iovs.05-1656","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9223_CR13","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","volume":"168","author":"N Jo","year":"2006","unstructured":"Jo N, Mailos C, Ju M et al (2006) Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 168:2036\u20132053. doi: 10.2353\/ajpath.2006.050588","journal-title":"Am J Pathol"},{"key":"9223_CR14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-2010-100219","volume":"21","author":"W Brown","year":"2010","unstructured":"Brown W (2010) A review of string vessels or collapsed, empty basement membrane tubes. J Alzheimer Dis 21:725\u2013739. doi: 10.3233\/JAD-2010-100219","journal-title":"J Alzheimer Dis"},{"key":"9223_CR15","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1167\/iovs.07-1329","volume":"49","author":"TI McKay","year":"2008","unstructured":"McKay TI, Gedeon DJ, Vickerman MB, Hylton AG, Ribita D, Olar HH, Kaiser PK, Parsons-Wingerter P (2008) Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide. Invest Ophthalmol Vis sci 49:1184\u20131190. doi: 10.1167\/iovs.07-1329","journal-title":"Invest Ophthalmol Vis sci"},{"key":"9223_CR16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1442-9071.2010.02252.x","volume":"38","author":"L Hoffart","year":"2010","unstructured":"Hoffart L, Matonti F, Conrath J, Daniel L, Ridings B, Masson G, Chavane F (2010) Inhibition of corneal neovascularization after alkali burn:comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone. Clin Exp Ophthalmol 38:346\u2013352. doi: 10.1111\/j.1442-9071.2010.02252.x","journal-title":"Clin Exp Ophthalmol"},{"key":"9223_CR17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ICO.0b013e3181b1c82f","volume":"29","author":"S Kang","year":"2010","unstructured":"Kang S, Chung SK (2010) The effect of subconjuntival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits. Cornea 29:192\u2013196. doi: 10.1097\/ICO.0b013e3181b1c82f","journal-title":"Cornea"},{"key":"9223_CR18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ajo.2009.07.009","volume":"148","author":"ML Subramanian","year":"2009","unstructured":"Subramanian ML, Ness S, Abedi G et al (2009) Bevacizumab versus ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial. Am J Ophthalmol 148:875\u2013882. doi: 10.1016\/j.ajo.2009.07.009","journal-title":"Am J Ophthalmol"},{"key":"9223_CR19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ajo.2009.10.010","volume":"149","author":"M Gharbiya","year":"2009","unstructured":"Gharbiya M, Giustolisi R, Allievi F, Fantozzi N, Mazzeo L, Scavella V, Balacco Gabrieli C (2009) Choroidal neovascularization in pathologic myopia: intravitreal ranibizumab versus bevacizumab\u2014a randomized controlled trial. Am J Ophthalmol 149:458\u2013464. doi: 10.1016\/j.ajo.2009.10.010","journal-title":"Am J Ophthalmol"},{"key":"9223_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000314721","volume":"45","author":"MASE Abdelhakim","year":"2011","unstructured":"Abdelhakim MASE, Macky TA, Mansour KAG, Mortada HA (2011) Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series. Ophthalmic Res 45:23\u201330. doi: 10.1159\/000314721","journal-title":"Ophthalmic Res"},{"key":"9223_CR21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1755-3768.2009.01585.x","volume":"88","author":"AA Zaki","year":"2010","unstructured":"Zaki AA, Farid SF (2010) Subconjunctival bevacizumab for corneal neovascularization. Acta Ophthalmol 88:868\u2013871. doi: 10.1111\/j.1755-3768.2009.0158.x","journal-title":"Acta Ophthalmol"},{"key":"9223_CR22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","volume":"127","author":"MH Dastjerdi","year":"2009","unstructured":"Dastjerdi MH, Al-Arfaj KM, Nallasamy N et al (2009) Topical bevacizumab in the treatment of corneal neovascularization. Arch Ophthalmol 127:381\u2013389. doi: 0.1001\/archophthalmol.2009.18","journal-title":"Arch Ophthalmol"},{"key":"9223_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","volume":"27","author":"I Bahar","year":"2008","unstructured":"Bahar I, Kaiserman I, McAllum P, Rootman D, Slomovic A (2008) Subconjunctival bevacizumab injection for corneal neovascularization. Cornea 27:142\u2013147. doi: 10.1097\/ICO.0b013e318159019f","journal-title":"Cornea"},{"key":"9223_CR24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","volume":"247","author":"Y Koening","year":"2009","unstructured":"Koening Y, Bock F, Horn F, Kruse F, Straub K, Cursiefen C (2009) Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin\u00ae) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 247:1375\u20131382. doi: 10.1007\/s00417-009-1099-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9223_CR25","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","volume":"48","author":"F Bock","year":"2007","unstructured":"Bock F, Onderka J, Dietrich T et al (2007) Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthlamol Vis Sci 48:2545\u20132552. doi: 11.1167\/iovs.06-0570","journal-title":"Invest Ophthlamol Vis Sci"},{"key":"9223_CR26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00417-008-0976-3","volume":"247","author":"YS Han","year":"2009","unstructured":"Han YS, Lee JE, Jung JW, Lee JS (2009) Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 247:541\u2013548. doi: 10.1007\/s00417-008-0976-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9223_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02713680802607740","volume":"34","author":"JY Oh","year":"2009","unstructured":"Oh JY, Kim MK, Shin MS, Lee HJ, Lee JH, Wee WR (2009) The anti-inflammatory effect of subconjunctival bevacizumab on chemically burned rat corneas. Curr Eye Res 34:85\u201391. doi: 10.1080\/02713680802607740","journal-title":"Curr Eye Res"},{"key":"9223_CR28","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1167\/iovs.09-3745","volume":"51","author":"M Dastjerdi","year":"2010","unstructured":"Dastjerdi M, Saban D, Okanobo A et al (2010) Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Invest Ophthalmol Vis Sci 51:2411\u20132417. doi: 10.1167\/iovs.09-3745","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9223_CR29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","volume":"150","author":"JJ P\u00e9rez-Santonja","year":"2010","unstructured":"P\u00e9rez-Santonja JJ, Campos-Mollo E, Lled\u00f3-Riquelme JavaloyJ, Ali\u00f3 J (2010) Inhibition of corneal neovascularization by topical bevacizumab (anti-VEGF) and sunitinib (ant-VEGF and anti-PDGF) in an animal model. Am J Ophthalmol 150:519\u2013528. doi: 10.1016\/j.ajo.2010.04.024","journal-title":"Am J Ophthalmol"},{"key":"9223_CR30","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.08-1997","volume":"50","author":"WL Chen","year":"2009","unstructured":"Chen WL, Lin CT, Lin NT et al (2009) Subconjunctival injection of bevacizumab (Avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis. Invest Ophthalmol Vis Sci 50:1659\u20131665. doi: 10.1167\/iovs.08-1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9223_CR31","first-page":"2326","volume":"15","author":"O Drativman-Storobinsky","year":"2009","unstructured":"Drativman-Storobinsky O, Lubin B, Hasanreisoglu M, Goldenberg-Cohen N (2009) Effect of subconjunctival and intra-ocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization. Mol Vis 15:2326\u20132338","journal-title":"Mol Vis"},{"key":"9223_CR32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/02713680903429007","volume":"35","author":"I Avisar","year":"2010","unstructured":"Avisar I, Weinberger D, Kremer I (2010) Effect of subconjunctival, intraocular bevacizumab injections on corneal neovascularization in a mouse model. Curr Eye Res 35:108\u2013115. doi: 10.3109\/02713680903429007","journal-title":"Curr Eye Res"},{"key":"9223_CR33","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1167\/iovs.10-6101","volume":"52","author":"B Bourghardt Peebo","year":"2011","unstructured":"Bourghardt Peebo B, Fagerholm P, Traneus-R\u00f6ckert C, Lagali N (2011) Time-lapse in vivo imaging of corneal angiogenesis: the role of inflammatory cells in capillary sprouting. Invest Ophthalmol Vis Sci 52:3060\u20133068. doi: 10.1167\/iovs.10-6101","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9223_CR34","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1167\/iovs.09-4407","volume":"51","author":"BB Peebo","year":"2010","unstructured":"Peebo BB, Fagerholm P, Traneus-R\u00f6ckert C, Lagali N (2010) Cellular-level characterization of lymph vessels in live, un-labeled corneas by in vivo confocal microscopy. Invest Ophthalmol Vis Sci 51:830\u2013835. doi: 10.1167\/iovs.09-4407","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9223_CR35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1167\/iovs.07-1175","volume":"49","author":"L Yu","year":"2008","unstructured":"Yu L, Wu X, Cheng Z et al (2008) Interaction between bevacizumab and murine VEGF-A: a reassessment. Invets Ophthalmol Vis Sci 49:522\u2013527. doi: 10.1167\/iovs.07-1175","journal-title":"Invets Ophthalmol Vis Sci"},{"key":"9223_CR36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jlb.55.3.410","volume":"55","author":"C Sunderk\u00f6tter","year":"1994","unstructured":"Sunderk\u00f6tter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C (1994) Macrophages and angiogenesis. J Leukocyte Biol. 55:410\u2013422","journal-title":"J Leukocyte Biol."},{"key":"9223_CR37","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood-2006-04-013755","volume":"108","author":"B Capoccia","year":"2006","unstructured":"Capoccia B, Shepherd RM, Link DC (2006) G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 108:2438\u20132444. doi: 10.1182\/blood-2006-04-013755","journal-title":"Blood"},{"key":"9223_CR38","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nbt1323","volume":"8","author":"F Shojaei","year":"2007","unstructured":"Shojaei F, Wu X, Malik AK et al (2007) Tumor refractoriness to anti-VEGF treatment is mediated by CD11b\u00a0+\u00a0Gr1\u00a0+\u00a0myeloid cells. Nature Biotech 8:911\u2013920. doi: 10.1038\/nbt1323","journal-title":"Nature Biotech"},{"key":"9223_CR39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10555-007-9094-7","volume":"26","author":"F Hillen","year":"2007","unstructured":"Hillen F, Griffioen AW (2007) Tumor vascularization: sprouting angiogenesis and beyond. Cancer Metastais Review 26:489\u2013502. doi: 10.1007\/s10555-007-9094-7","journal-title":"Cancer Metastais Review"},{"key":"9223_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10456-009-9129-5","volume":"12","author":"AN Makanaya","year":"2008","unstructured":"Makanaya AN, Hlushchuk R, Djonov VG (2008) Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning and remodeling. Angiogenesis 12:113\u2013123. doi: 10.1007\/s10456-009-9129-5","journal-title":"Angiogenesis"},{"key":"9223_CR41","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2353\/ajpath.2008.071131","volume":"173","author":"R Hlushchuk","year":"2008","unstructured":"Hlushchuk R, Riesterer O, Baum O, Wood J, Gruber G, Pruschy M, Djonov V (2008) Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787\/ZK222584 or ionizing radiation. Am J Path 173:1173\u20131185. doi: 10.2353\/ajpath.2008.071131","journal-title":"Am J Path"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-011-9223-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-011-9223-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-011-9223-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T21:24:57Z","timestamp":1638048297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-011-9223-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,10]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["9223"],"URL":"https:\/\/doi.org\/10.1007\/s10456-011-9223-3","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,10]]}}}